Donepezil
Who holds supplier records for Donepezil? 2 organisations hold a current record for Donepezil: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1) and Israel (1).
Most records are filed under another form of this substance: Donepezil Hydrochloride (24 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Donepezil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/donepezil
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Donepezil expires 4 Oct 2026. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Donepezil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 19286 · latest filing Mar 2006
- WAVELENGTH ENTERPRISES LTDIsrael Company GMP cert on recordActive DMF 24082 · latest filing Aug 2010
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Donepezil are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 23008 · filed Aug 2009
- India · Inactive DMF 18422 · filed Jun 2005
- PERRIGO API LTDInactive DMF 17523 · filed Jul 2004
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (42 listed products contain Donepezil). The latest listed patent expires 4 Oct 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Donepezil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL502).
Chemical identity
- IUPAC name
- 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
- Canonical SMILES
- COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
- InChIKey
- ADEBPBSSDYVVLD-UHFFFAOYSA-N
- Synonyms
- D-797, Donaz, Donepezil, Donepezilo, donepezilum, Domepezil, CHEBI:53289, donezpil hydrochloride, donepezil hydrochlorid, RefChem:5777, N06DA02, Aricept
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Donepezil?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for Donepezil: USV PRIVATE LTD (India) and WAVELENGTH ENTERPRISES LTD (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Donepezil Drug Master Files are active?
USV PRIVATE LTD (DMF 19286) and WAVELENGTH ENTERPRISES LTD (DMF 24082). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Donepezil records mean?
3 organisations have only inactive Type II DMFs for Donepezil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Donepezil?
Yes. The latest patent listed for an approved US product containing Donepezil expires 4 Oct 2026, across 42 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Donepezil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Donepezil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.